GENE ONLINE|News &
Opinion
Blog

Ranking & Reports
Patent Landscape Analysis of Canine Vaccines
2023-01-04
GeneOnline’s Pick: Top 10 New FDA-approved Drugs in 2022
2022-12-30
GeneOnline’s Pick: Top 10 M&A Deals in 2022
2022-12-28
GeneOnline’s Pick: Top 10 Industry News Stories in 2022
2022-12-26
A Force To Be Reckoned With – BioBetter Biologics
2022-12-14
2026: The Promise of Synthetic Biology
2022-08-11
Market Insight on FDA-approvals: Rise of First-in-class and Regenerative Innovations
2022-03-17
Cure or Poison? New Ventures Go IPO Continuously As “Psychedelics” Enter the Mental Health Market
2022-03-09
GeneOnline’s Pick: Notable Novel FDA Approved Drugs in 2021
2022-01-05
9 Leading Molecular Diagnostics Companies to Watch in Taiwan
2021-11-15
The 8 Companies Propelling Taiwan’s Biopharma Industry
2021-10-21
Taiwan’s Biotech Industry, Lackluster or Late Bloomer? A Breakdown of Policies, Hotspots, and Market Movements
2021-10-05
The 6 Companies Leading the Resurgence in RNA Editing R&D
2021-08-24
10 Precision Oncology Companies to Look Out for
2021-05-27
10 Top Gene Therapy Companies in 2021
2021-03-26
1 2 3
LATEST
NDA for Biogen-Sage’s Zuranolone Accepted by FDA, Marking Another Step Forward in Depression Drug Development
2023-02-07
BMS Returns $475 Million Cancer Asset To Dragonfly Therapeutics
2023-02-07
FDA Expands Approval For Takeda’s Takhzyro To Prevent Hereditary Angioedema Attacks
2023-02-06
Abbott’s New Technologies for Arrhythmia Treatment Secure FDA and European Approval
2023-02-04
First Human Trial for Marburg Virus Vaccine Reports Success
2023-02-03
Karuna Licenses Goldfinch’s Mood Disorder Candidates For Potential $535 Million
2023-02-03
Novel Bioengineered Wearable Edgeless Skin Brings Hope to Revolutionize Plastic and Reconstructive Surgery
2023-02-03
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!